Lurbinectedin
Records for this ingredient, by country (identity only).
ATC L01XX69 · 8 markets · 11 records
AU 3 records · 2 shown of 2
- 4 mg per mL / per unit basis not statedinjectionZEPZELCA lurbinectedin 4 mg powder for solution for infusion 1 vial per carton
- 2 mg per mL / per unit basis not statedinjectionZEPZELCA lurbinectedin 2 mg powder for solution for infusion vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 0.5 mg per mL / per unit basis not statedinjectionZEPZELCA
SG 1 records · 1 shown of 1
- 4 mg/vial per mL / per unit basis not statedinjectionZEPZELCA POWDER FOR SOLUTION FOR INFUSION 4MG/VIAL
TW 1 records · 1 shown of 1
- 4 mg per mL / per unit basis not statedinjectionZEPZELCA lyophilized powder for solution for infusion 4 mg贊必佳凍晶注射劑4毫克
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | AU | SG | TW | HK | EU |
|---|---|---|---|---|---|---|
| 4 mg per mL / per unit basis not stated cannot compare injection | ZEPZELCA lurbinectedin 4 mg powder for solution for infusion 1 vial per carton | ZEPZELCA lyophilized powder for solution for infusion 4 mg 贊必佳凍晶注射劑4毫克 | ||||
| 4 mg/vial per mL / per unit basis not stated cannot compare injection | ZEPZELCA POWDER FOR SOLUTION FOR INFUSION 4MG/VIAL | |||||
| 2 mg per mL / per unit basis not stated cannot compare injection | ZEPZELCA lurbinectedin 2 mg powder for solution for infusion vial | |||||
| 0.5 mg per mL / per unit basis not stated cannot compare injection | ZEPZELCA | |||||
unknown | ZEPZELCA | ZEPZELCA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 4MG | ZEPZELCA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in SG and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en SG que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 SG 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 SG 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.